Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind active-controlled trial of flurbiprofen axetil injection for postoperative analgesia
CTR20223269Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flurbiprofen axetil in postoperative pain, cancer pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Dec 2022; status: completed.
02
Drugs
flurbiprofen axetil
03
Conditions
postoperative paincancer pain
Beyond the preview
Go deeper on CTR20223269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223269.